Page 1 of Clinical Trials for Roswell Park Cancer Institute [SPONSOR-COLLABORATORS], 195 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer Patients
Last Updated: October 18, 2011
Condition(s): Breast Cancer
2
Recruiting
Bathing Bundle Regimen in Reducing Gynecological Surgical Site Infection in Patients Undergoing Surgery
Last Updated: May 10, 2012
Condition(s): Female Reproductive Cancer
3
Recruiting
Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate
Last Updated: April 19, 2012
Condition(s): Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage III Renal Cell Cancer; Stage IV Renal Cell Cancer
4
Completed
Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer
Last Updated: February 8, 2012
Condition(s): Prostate Cancer
5
Not yet recruiting
Edible Hepatitis B Vaccine Therapy in Healthy Participants Who Have Undergone Previous Vaccination
Last Updated: January 11, 2012
Condition(s): Healthy, no Evidence of Disease
6
Recruiting
Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung Cancer
Last Updated: December 6, 2011
Condition(s): Lung Cancer; Precancerous Condition; Tobacco Use Disorder
7
Completed
Acceptability of Less Harmful Alternatives to Cigarettes
Last Updated: March 5, 2012
Condition(s): Bladder Cancer; Cervical Cancer; Esophageal Cancer; Gastric Cancer; Head and Neck Cancer; Kidney Cancer; Leukemia; Liver Cancer; Lung Cancer; Pancreatic Cancer; Tobacco Use Disorder
8
Completed
Folate-Depleted Diet Compared With Folate-Supplemented Diet in Preventing Colorectal Cancer in Patients at High Risk for Colorectal Cancer
Last Updated: February 6, 2012
Condition(s): Colorectal Cancer
9
Completed
Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors
Last Updated: January 11, 2012
Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
10
Active, not recruiting
Cholecalciferol in Treating Patients With Acute Myeloid Leukemia Undergoing Intensive Induction Chemotherapy
Last Updated: April 25, 2012
Condition(s): Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Untreated Adult Acute Myeloid Leukemia
11
Completed
Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
Last Updated: March 7, 2011
Condition(s): Leukemia
12
Recruiting
Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed By Surgery
Last Updated: February 15, 2012
Condition(s): Recurrent Melanoma; Stage IIIA Melanoma; Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV Melanoma
13
Not yet recruiting
Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Last Updated: February 15, 2012
Condition(s): Recurrent Fallopian Tube Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Primary Peritoneal Cavity Cancer; Stage IIA Fallopian Tube Cancer; Stage IIA Ovarian Epithelial Cancer; Stage IIA Primary Peritoneal Cavity Cancer; Stage IIB Fallopian Tube Cancer; Stage IIB Ovarian Epithelial Cancer; Stage IIB Primary Peritoneal Cavity Cancer; Stage IIC Fallopian Tube Cancer; Stage IIC Ovarian Epithelial Cancer; Stage IIC Primary Peritoneal Cavity Cancer; Stage IIIA Fallopian Tube Cancer; Stage IIIA Ovarian Epithelial Cancer; Stage IIIA Primary Peritoneal Cavity Cancer; Stage IIIB Fallopian Tube Cancer; Stage IIIB Ovarian Epithelial Cancer; Stage IIIB Primary Peritoneal Cavity Cancer; Stage IIIC Fallopian Tube Cancer; Stage IIIC Ovarian Epithelial Cancer; Stage IIIC Primary Peritoneal Cavity Cancer; Stage IV Fallopian Tube Cancer; Stage IV Ovarian Epithelial Cancer; Stage IV Primary Peritoneal Cavity Cancer
14
Completed
Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases
Last Updated: March 3, 2011
Condition(s): Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Thymic Carcinoma
15
Terminated
Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate
Last Updated: September 23, 2011
Condition(s): Prostate Cancer
16
Withdrawn
Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer
Last Updated: February 3, 2012
Condition(s): Prostate Cancer
17
Recruiting
Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer
Last Updated: May 15, 2012
Condition(s): Basal Cell Carcinoma of the Skin; Pain; Recurrent Skin Cancer
18
Completed
Photodynamic Therapy in Treating Patients With Skin Cancer
Last Updated: September 23, 2011
Condition(s): Non-melanomatous Skin Cancer; Precancerous Condition
19
Completed
Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer
Last Updated: March 3, 2011
Condition(s): Breast Cancer
20
Completed
Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors
Last Updated: April 25, 2012
Condition(s): Colorectal Cancer; Unspecified Adult Solid Tumor, Protocol Specific

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Roswell+Park+Cancer+Institute

Page 1 of Clinical Trials for Roswell Park Cancer Institute [SPONSOR-COLLABORATORS], 195 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About